Guangzhou Boji Medical and Biotechnological Co Ltd Strategic Asset Allocation Index
Guangzhou Boji Medical and Biotechnological Co Ltd strategic asset allocation index. Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a Strategic Asset Allocation Index of 35.1% as of June 2023. Strategic assets (PP&E of CN¥322.46 Million plus long-term investments of CN¥-) total CN¥322.46 Million, measured against net assets of CN¥918.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Guangzhou Boji Medical and Biotechnologi balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2021)
Strategic asset allocation index of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2021. This chart shows how Guangzhou Boji Medical and Biotechnological Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 35.1%, representing strategic assets of CN¥322.46 Million against net assets of CN¥918.92 Million CNY. Check 300404 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Guangzhou Boji Medical and Biotechnological Co Ltd Strategic Asset Allocation Index by Year (2012–2021)
Guangzhou Boji Medical and Biotechnological Co Ltd strategic asset allocation index by year from 2012 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangzhou Boji Medical and Biotechnologi stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 26.7% | CN¥225.78 Million | CN¥225.78 Million | CN¥- | CN¥846.38 Million | ▼ -11.6 pp |
| 2020 | 38.3% | CN¥185.86 Million | CN¥185.86 Million | CN¥- | CN¥485.00 Million | ▼ -6.5 pp |
| 2019 | 44.8% | CN¥204.52 Million | CN¥204.52 Million | CN¥- | CN¥456.08 Million | ▼ -10.1 pp |
| 2018 | 54.9% | CN¥232.66 Million | CN¥200.17 Million | CN¥32.50 Million | CN¥423.71 Million | ▲ +4.7 pp |
| 2017 | 50.2% | CN¥207.91 Million | CN¥190.39 Million | CN¥17.52 Million | CN¥414.35 Million | ▲ +13.1 pp |
| 2016 | 37.1% | CN¥159.37 Million | CN¥143.12 Million | CN¥16.25 Million | CN¥429.84 Million | ▲ +19.7 pp |
| 2015 | 17.4% | CN¥75.31 Million | CN¥68.81 Million | CN¥6.50 Million | CN¥432.68 Million | ▼ -11.2 pp |
| 2014 | 28.6% | CN¥62.57 Million | CN¥62.57 Million | CN¥- | CN¥218.48 Million | ▼ -1.6 pp |
| 2013 | 30.2% | CN¥62.11 Million | CN¥62.11 Million | CN¥- | CN¥205.52 Million | ▼ -4.7 pp |
| 2012 | 34.9% | CN¥59.47 Million | CN¥59.47 Million | CN¥- | CN¥170.36 Million | — |